Search research articles
Contact Us
Filters
Showing results (321-330 of 382) with videos related to
Page
of 39
Sort By:
Blood Cancer Journal
|
January 29, 2022
Chronic lymphocytic leukemia (CLL) with Reed-Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter?
Rebecca L King, Alia Gupta, Paul J Kurtin, et al.
American Journal of Hematology
|
February 24, 2017
A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapy
Allison Rosenthal, Amylou C Dueck, Stephen Ansell, et al.
British Journal of Haematology
|
August 31, 2019
Ibrutinib monotherapy outside of clinical trial setting in Waldenström macroglobulinaemia: practice patterns, toxicities and outcomes
Jithma P Abeykoon, Saurabh Zanwar, Stephen M Ansell, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 25, 2008
Allogeneic transplants in follicular lymphoma: higher risk of disease progression after reduced-intensity compared to myeloablative conditioning
Parameswaran Hari, Jeanette Carreras, Mei-Jie Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 22, 2013
Allogeneic hematopoietic cell transplantation for chemotherapy-unresponsive mantle cell lymphoma: a cohort analysis from the center for international blood and marrow transplant research
Mehdi Hamadani, Wael Saber, Kwang Woo Ahn, et al.
American Journal of Hematology
|
April 27, 2013
A phase I trial of immunostimulatory CpG 7909 oligodeoxynucleotide and 90 yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B-cell non-Hodgkin lymphoma
Thomas E Witzig, Gregory A Wiseman, Matthew J Maurer, et al.
Leukemia
|
November 5, 2004
A phase I study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma
A Dispenzieri, G A Wiseman, M Q Lacy, et al.
Blood
|
August 2, 2003
Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma
Koen van Besien, Fausto R Loberiza, Ruta Bajorunaite, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 2014
Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma
Carrie A Thompson, Herve Ghesquieres, Matthew J Maurer, et al.
International Journal of Epidemiology
|
October 13, 2017
Cohort Profile: The Lymphoma Specialized Program of Research Excellence (SPORE) Molecular Epidemiology Resource (MER) Cohort Study
James R Cerhan, Brian K Link, Thomas M Habermann, et al.
Page
of 39
Search research articles
Search
Showing results (321-330 of 382) with videos related to
Sort By:
Page
of 39
Blood Cancer Journal
|
January 29, 2022
Chronic lymphocytic leukemia (CLL) with Reed-Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter?
Rebecca L King, Alia Gupta, Paul J Kurtin, et al.
American Journal of Hematology
|
February 24, 2017
A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapy
Allison Rosenthal, Amylou C Dueck, Stephen Ansell, et al.
British Journal of Haematology
|
August 31, 2019
Ibrutinib monotherapy outside of clinical trial setting in Waldenström macroglobulinaemia: practice patterns, toxicities and outcomes
Jithma P Abeykoon, Saurabh Zanwar, Stephen M Ansell, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 25, 2008
Allogeneic transplants in follicular lymphoma: higher risk of disease progression after reduced-intensity compared to myeloablative conditioning
Parameswaran Hari, Jeanette Carreras, Mei-Jie Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 22, 2013
Allogeneic hematopoietic cell transplantation for chemotherapy-unresponsive mantle cell lymphoma: a cohort analysis from the center for international blood and marrow transplant research
Mehdi Hamadani, Wael Saber, Kwang Woo Ahn, et al.
American Journal of Hematology
|
April 27, 2013
A phase I trial of immunostimulatory CpG 7909 oligodeoxynucleotide and 90 yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B-cell non-Hodgkin lymphoma
Thomas E Witzig, Gregory A Wiseman, Matthew J Maurer, et al.
Leukemia
|
November 5, 2004
A phase I study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma
A Dispenzieri, G A Wiseman, M Q Lacy, et al.
Blood
|
August 2, 2003
Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma
Koen van Besien, Fausto R Loberiza, Ruta Bajorunaite, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 2014
Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma
Carrie A Thompson, Herve Ghesquieres, Matthew J Maurer, et al.
International Journal of Epidemiology
|
October 13, 2017
Cohort Profile: The Lymphoma Specialized Program of Research Excellence (SPORE) Molecular Epidemiology Resource (MER) Cohort Study
James R Cerhan, Brian K Link, Thomas M Habermann, et al.
Page
of 39